EUVIMEDEUVIMED entdecken
Open Access

Deoxybouvardin Glucoside Induces Apoptosis in Oxaliplatin-Sensitive and -Resistant Colorectal Cancer Cells via Reactive Oxygen Species-Mediated Activation of JNK and p38 MAPK

Seung-On Lee, Sang Hoon Joo, Jisu Park, Quan T Khong, Si Yeong Seo, Goo Yoon, Jin Woo Park, MinKyun Na, Jung-Hyun Shim

Journal of Microbiology and Biotechnology · 2025

DOI: 10.4014/jmb.2410.10008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Seung-On Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Kor…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Apoptosis, p38 Mitogen-Activated Protein Kinases, Colorectal Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The roots of Rubia spp. (Rubiaceae) have been employed to treat hematemesis, inflammatory disease, and tumor. Cyclohexapeptides derived from Rubia spp. have been reported to have antitumor potential; however, the mechanism of action for their antitumor activity remains unclear. We aimed to examine the antitumor effect of deoxybouvardin glucoside (DBG), a cyclohexapeptide from Rubia spp. on oxaliplatin (Ox)-resistant human HCT116 colorectal cancer (CRC) cells. Cell viability in the presence of DBG was monitored using an MTT viability assay, and flow cytometry was used to analyze changes in apoptosis, cell cycle, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) activity. The antiproliferative activity involved apoptosis and phosphorylation of JNK and p38 MAPK. Inhibition of JNK and p38 MAPK by specific inhibitors prevented DBG-induced apoptosis, underscoring the close involvement of these kinases. Further, DBG induced cell cycle arrest in CRC cells at the G2/M phase by regulating the p21, p27, cyclin B1, and cdc2 proteins. DBG-induced apoptosis was accompanied mitochondrial membrane depolarization, resulting in cytochrome c release into the cytoplasm and caspase activation. Remarkably, DBG induced apoptosis by generating high ROS levels. The mediation of apoptosis by increased ROS generation was confirmed by pretreatment with the ROS scavenger N-acetyl cysteine (NAC). Collectively, DBG exhibited anticancer activity against both Ox-sensitive and Ox-resistant CRC cells by targeting JNK and p38 MAPK, inducing cell cycle arrest, elevating cellular ROS levels, and disrupting MMP. This study suggests that DBG has the potential to be utilized as a therapeutic agent for treating Ox-resistant CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesApoptosisp38 Mitogen-Activated Protein KinasesColorectal NeoplasmsAntineoplastic AgentsGlucosidesOrganoplatinum CompoundsJNK Mitogen-Activated Protein KinasesHumansOxaliplatinHCT116 CellsMembrane Potential, MitochondrialDrug Resistance, NeoplasmCell SurvivalCell ProliferationCell Cycle CheckpointsCell Line, TumorPhosphorylation

Stichwörter der Autor:innen

Deoxybouvardin glucosideJNKapoptosiscolorectal cancerp38 MAPKreactive oxygen species

Substanzen

Reactive Oxygen Speciesp38 Mitogen-Activated Protein KinasesOxaliplatinAntineoplastic AgentsGlucosidesOrganoplatinum CompoundsJNK Mitogen-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea.
  • College of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea.
  • College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Mokpo National University, Muan 58554, Republic of Korea.
  • The China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, P.R. China.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Lee, S. O., Joo, S. H., Park, J., Khong, Q. T., Seo, S. Y., Yoon, G., Park, J. W., Na, M., & Shim, J. H. (2025). Deoxybouvardin Glucoside Induces Apoptosis in Oxaliplatin-Sensitive and -Resistant Colorectal Cancer Cells via Reactive Oxygen Species-Mediated Activation of JNK and p38 MAPK. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2410.10008

Vancouver

Lee SO, Joo SH, Park J, Khong QT, Seo SY, Yoon G, et al. Deoxybouvardin Glucoside Induces Apoptosis in Oxaliplatin-Sensitive and -Resistant Colorectal Cancer Cells via Reactive Oxygen Species-Mediated Activation of JNK and p38 MAPK. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2410.10008

BibTeX
@article{Lee2025,
  author = {Lee, Seung-On and Joo, Sang Hoon and Park, Jisu and Khong, Quan T and Seo, Si Yeong and Yoon, Goo and Park, Jin Woo and Na, MinKyun and Shim, Jung-Hyun},
  title = {Deoxybouvardin Glucoside Induces Apoptosis in Oxaliplatin-Sensitive and -Resistant Colorectal Cancer Cells via Reactive Oxygen Species-Mediated Activation of JNK and p38 MAPK},
  journal = {Journal of Microbiology and Biotechnology},
  year = {2025},
  doi = {10.4014/jmb.2410.10008}
}
Kostenlos starten →